1
FDA announced on Nov 06, 2025, the award of its second batch of Commissioner’s National Priority Vouchers (CNPV) pilot program recipients (1). This cohort adds six awardees, bringing the total number of voucher recipients to 15. According to the Nov 6 news release, the agency is committed to accelerating the review of products that address key national priorities. FDA Commissioner Marty Makary, MD, MPH, stated that the agency is “pioneering new ways of bringing these cures and meaningful treatments to the market faster” (1).
These vouchers are highly selective, granted only when the company agrees to increase affordability, domesticate…